Get started
Author

Amulya Yellala

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions
2021 · Victor Manuel Orellana-Noia, Daniel R. Reed, et al. · Blood · 94
PDF
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025
2025 · William J. Gradishar, Meena S. Moran, et al. · Journal of the National Comprehensive Cancer Network · 86
Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis
2024 · Meghana Kesireddy, Lina Elsayed, et al. · Cancers · 63
CNS Prophylaxis during Front-Line Therapy in Aggressive Non-Hodgkin Lymphomas: Real-World Outcomes and Practice Patterns from 19 US Academic Institutions
2020 · Victor M. Orellana-Noia, Daniel R Reed, et al. · Blood · 11
Risk factors for venous thromboembolism in hospitalized patients with hematological malignancy: an analysis of the National Inpatient Sample, 2011–2015
2019 · Veli Bakalov, Amy Tang, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 11
Aggressive Disease and Rare Sequelae in a Unique Case of Atypical Hemolytic Uremic Syndrome Secondary to Adult Onset Still’s Disease
2019 · Ahmed Khattab, Amulya Yellala, et al. · Journal of Hematology · 7
Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology
2026 · William J. Gradishar, Meena S. Moran, et al. · Journal of the National Comprehensive Cancer Network · 6
Primary renal synovial sarcoma – a diagnostic dilemma
2018 · Amulya Yellala · The Journal of Community and Supportive Oncology · 5
PDF
Overall Survival and Prognostic Factors in De Novo Metastatic Human Epidermal Growth Factor Receptor (HER)-2-Positive Breast Cancer: A National Cancer Database Analysis
2025 · Meghana Kesireddy, Durva Masih, et al. · Cancers · 3
PDF
Thirty-Five Year Follow-up Analysis of Follicular Lymphoma Patients Treated through the Nebraska Lymphoma Study Group: Prognostic Factor Analysis and Outcomes
2020 · Amulya Yellala, Elizabeth R. Lyden, et al. · Blood · 2
Exploratory analysis of the spatial distribution of adult glioma age-adjusted county incidence rates, Nebraska Medicine, 2009–2019
2023 · Kendra L Ratnapradipa, Amulya Yellala, et al. · Neuro-Oncology Practice · 1
PDF
Evaluation of high-dose methotrexate serum concentration requirement for discharge.
2020 · Amulya Yellala, Prajwal Dhakal, et al. · Journal of Clinical Oncology · 1
Risk factors for opioid abuse/dependence in hospitalized cancer patients in the United States.
2019 · Veli Bakalov, Amy Tang, et al. · Journal of Clinical Oncology · 1
Elbow to Lung: Cancer is the Connection
2017 · Chinmaya Mareddy, Amulya Yellala, et al. · CHEST Journal · 1
Age and sex-based differences in therapy preferences among patients with cancer: evidence from a novel therapy preference scale
2026 · Prajwal Dhakal, Christopher S Wichman, et al. · ecancermedicalscience
PDF
Toxicity and Outcomes of the KEYNOTE-522 Chemo-immunotherapy Regimen in Non-Metastatic Triple-negative Breast Cancer," for consideration for publication in the
2025 · Lina M. Adwer, Mackenzie Jones, et al. · Research Square
PDF
Abstract P3-08-12: Poor Response of Metaplastic Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy: An Unmet Oncological Need
2025 · Sara B. Cartwright, Heng Jiang, et al. · Clinical Cancer Research
Age and Sex-Based Differences in Therapy Preferences Among Patients with Cancer: Evidence from a Novel Therapy Preference Scale
2025 · Prajwal Dhakal, Christopher S. Wichman, et al. · Research Square
PDF
Clinical Trial Eligibility and Outcomes in Patients With Metastatic NSCLC Treated Outside of Clinical Trials
2024 · Clayton K Oakley, Amulya Yellala, et al. · ONCOLOGY
CLO24-082: A National Cancer Data Base (NCDB) Analysis of Prognostic Factors in Metastatic Triple-Negative Breast Cancer (TNBC)
2024 · Priyal Agarwal, Amulya Yellala, et al. · Journal of the National Comprehensive Cancer Network
Therapy preferences of patients with cancer.
2023 · Prajwal Dhakal, Christopher S. Wichman, et al. · Journal of Clinical Oncology
ABCL-455 Multicenter Retrospective Analysis of Single-Route Prophylaxis in Aggressive B-Cell Lymphomas
2022 · Victor Orellana-Noia, Daniel Reed, et al. · Clinical Lymphoma Myeloma & Leukemia
Poster: ABCL-455 Multicenter Retrospective Analysis of Single-Route Prophylaxis in Aggressive B-Cell Lymphomas
2022 · Victor Orellana-Noia, Daniel Reed, et al. · Clinical Lymphoma Myeloma & Leukemia
P10.01 Real World Data of Clinical Trial Eligibility and Outcome Analysis in Patients With Metastatic NSCLC
2021 · A. Yellala, S. Tulpule, et al. · Journal of Thoracic Oncology
Geographic Distribution of the Peripheral T‐cell Lymphomas
2021 · Amulya Yellala, Avyakta Kallam, et al.
Works count: 32
Citation count: 292
H-index: 6
I10-index: 5
Year
Topic
Type